Loading...

FITC anti-mouse Ly-6G Antibody

Pricing & Availability
Clone
1A8 (See other available formats)
Regulatory Status
RUO
Other Names
Lymphocyte antigen 6 complex, locus G
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
1A8_FITC_082808.jpg
BALB/cmouse bone marrow cells stained with 1A8 FITC (gated on myeloid cells)
  • 1A8_FITC_082808.jpg
    BALB/cmouse bone marrow cells stained with 1A8 FITC (gated on myeloid cells)
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
127605 50 µg 72€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
127606 500 µg 210€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Lymphocyte antigen 6 complex, locus G (Ly-6G), a 21-25 kD GPI-anchored protein, is expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Ly-6G transfected EL-4J cell line.
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for other applications.

Excitation Laser
Blue Laser (488 nm)
Application Notes

While 1A8 recognizes only Ly-6G, clone RB6-8C5 recognizes both Ly-6G and Ly-6C. Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C15. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A815. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.416.

Additional reported applications (for the relevant formats) include: immunohistochemistry9 of frozen sections10 and paraffin-embedded sections11, depletion4, 12-14, and spatial biology (IBEX)20,21. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for in vivo studies or highly sensitive assays (Cat. No. 127632, 127649, 127650, 127661 and 127662).

Application References
  1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (FC)
  2. Daley JM, et al. 2008. J. Leukocyte Biol. 83:1. (FC)
  3. Dietlin TA, et al. 2007. J. Leukocyte Biol. 81:1205. (FC)
  4. Daley J, et al. 2007. J. Leukocyte Biol. doi:10.1189. (Deplete) PubMed
  5. Tadagavadi RK, et al. 2010. J. Immunol. 185:4904. PubMed
  6. Sumagin R, et al. 2010. J. Immunol. 185:7057. PubMed
  7. Guiducci C, et al. 2010. J. Exp Med. 207:2931. PubMed
  8. Fujita M, et al. 2011. Cancer Res. 71:2664. PubMed
  9. Van Leeuwen, et al. 2008. Arterioscler. Thromb. Vasc. Biol. 28:84. (IHC)
  10. Kowanetz M, et al. 2010. P. Natl. Acad. Sci. USA 107:21248. [supplementary data] (IHC)
  11. Esbona K, et al. 2016. Breast Cancer Res. 18:35. (IHC)
  12. Wojtasiak M, et al. 2010. J. Gen. Virol. 91:2158. (FC, Deplete)
  13. Jaeger BN, et al. 2012. J. Exp. Med. 209:565. (Deplete)
  14. Wozniak KL, et al. 2012. BMC Immunol. 13:65 (FC, Deplete)
  15. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  16. Ng LG, et al. 2011. J Invest. Dermatol. 131:2058. PubMed
  17. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  18. McCartney-Francis, N, et al. 2014. J Leukoc. Biol. 96:917. PubMed
  19. Her Z, et al. 2014. EMBO Mol. Med. 7:24. PubMed
  20. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  21. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Valladao A, et al. 2016. J Immunol. 197(12):4541-4551. PubMed
  2. Campbell IK, Leong D 2016. J Immunol. 197(11):4392-4402. PubMed
  3. Tomida S, et al. 2019. Sci Rep. 9:10751. PubMed
  4. Gordan S, et al. 2020. Cell Reports. 29(10):3033-3046.e4.. PubMed
  5. Frieler RA, et al. 2017. Exp Neurol. 298:104. PubMed
  6. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  7. Pohlmeier L, et al. 2021. Allergy. 76:2030. PubMed
  8. Li T, et al. 2022. J Exp Med. 219: . PubMed
  9. Yang Y, et al. 2022. FEBS J. 289:5279. PubMed
  10. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  11. Zhu Y, et al. 2023. J Ethnopharmacol. 301:115763. PubMed
  12. Xu Y, et al. 2023. EMBO Rep. 24:e55503. PubMed
  13. Xu H, et al. 2022. Aging Dis. 13:1875. PubMed
  14. Pavliuchenko N, et al. 2023. Front Immunol. 13:1035226. PubMed
  15. Tsioti I, et al. 2023. J Neuroinflammation. 20:25. PubMed
  16. Zong P, et al. 2022. Nat Cardiovasc Res. 1:344. PubMed
  17. Sanmarco LM, et al. 2022. Nature. 611:801. PubMed
  18. Peng J, et al. 2023. Am J Reprod Immunol. 89:e13678. PubMed
  19. Le DT, et al. 2023. iScience. 26:106059. PubMed
  20. Veras FP, et al. 2023. Respir Res. 24:66. PubMed
  21. Doke T, et al. 2023. Nat Metab. 5:414. PubMed
  22. Tang C, et al. 2023. Nat Commun. 14:1493. PubMed
  23. Senatus L, et al. 2023. Commun Biol. 6:280. PubMed
  24. Ma X, et al. 2023. Nat Commun. 14:1606. PubMed
  25. Park JA, et al. 2023. J Immunother Cancer. 11:. PubMed
  26. Chung JY, et al. 2023. Nat Commun. 14:1794. PubMed
  27. Zhu CL, et al. 2023. Int J Biol Sci. 19:1413. PubMed
  28. Silva BM, et al. 2023. J Clin Invest. 133:. PubMed
  29. Cui B, et al. 2023. Int Immunopharmacol. 120:110240. PubMed
  30. Oh J, et al. 2023. Nat Commun. 14:3278. PubMed
  31. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
  32. Oliveira-Lima OC, et al. 2015. Immunobiology. . PubMed
  33. Mandraju R, et al. 2014. J Immunol. 192:4303. PubMed
  34. Golden GJ, et al. 2021. MBio. 12:e0118121. PubMed
  35. He R, et al. 2021. J Immunol. 206:2353. PubMed
  36. Lefebvre MN, et al. 2021. Cell Rep. 37:109956. PubMed
  37. Suresh R, et al. 2020. J Immunother Cancer. 8:. PubMed
  38. Okajima T, et al. 2021. Front Immunol. 12:738041. PubMed
  39. Tripathi H, et al. 2020. J Mol Cell Cardiol. 149:95. PubMed
  40. Kim S, et al. 2020. Immunity. 53(4):759-774.e9. PubMed
  41. Garcia-Fabiani MB, et al. 2020. Methods Enzymol. 632:369. PubMed
  42. Miller CM, et al. 2020. J Virol. 94:00:00. PubMed
  43. Long M, et al. 2017. J Immunol. 198(2):862-872. PubMed
  44. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  45. Lin R, et al. 2020. Sci Rep. 10:14397. PubMed
  46. Patsalos A, et al. 2019. J Immunol. 203:1532. PubMed
  47. Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  48. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  49. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  50. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  51. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  52. Torre S, et al. 2016. Nat Immunol. 10.1038/ni.3581. PubMed
  53. Montufar-Solis D, Klein J 2016. PLoS One. 11: 014611. PubMed
  54. Wang C, et al. 2015. Sci Rep. 5: 14124. PubMed
  55. Huai W, et al. 2019. J Exp Med. 216:772. PubMed
  56. Han J, et al. 2022. FEBS J. 289:417. PubMed
  57. Larsen SE, et al. 2021. Sci Rep. 11:9040. PubMed
  58. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  59. Castiglioni A, et al. 2015. PLoS One. 10:128094. PubMed
  60. Guesdon W, et al. 2015. J Infect Dis. 212: 1332 - 1340. PubMed
  61. Strother R, et al. 2016. J Immunol. 197(11):4301-4311. PubMed
  62. Bae SH, et al. 2021. Theranostics. 11:2522. PubMed
  63. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  64. Mitsune A, et al. 2021. Respir Res. 22:232. PubMed
  65. Rao S, et al. 2017. Cell. 168(3):503-516.e12. PubMed
  66. LeBlond ND, et al. 2020. J Lipid Res. 61:1697. PubMed
  67. Park JA, et al. 2021. J Hematol Oncol. 14:142. PubMed
  68. Diao N, et al. 2016. Sci Rep. 6:34672. PubMed
  69. Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed
  70. Fujikura D, et al. 2013. PLoS One. 8:e55321. PubMed
  71. Ueki H, et al. 2020. Nat Protoc. 15:1041. PubMed
  72. Saika A, et al. 2020. FASEB Bioadv. 2:59. PubMed
  73. Nguyen CM, et al. 2019. Diabetes. 68:1499. PubMed
  74. Wang H et al. 2017. Developmental cell. 40(6):566-582 . PubMed
  75. Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed
  76. Billi AC, et al. 2019. JCI Insight. 4:8. PubMed
  77. Han YH, et al. 2021. Science. 373:. PubMed
  78. Dieterich LC, et al. 2019. International Journal of Cancer. 145(10):2804-2815. PubMed
  79. Abad C, et al. 2014. J Leukoc Biol. 95:357. PubMed
  80. Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
  81. Liu Z, et al. 2016. J Biol Chem. 291: 1441 - 1447. PubMed
  82. Wang L, et al. 2017. Front Immunol.. 10.3389/fimmu.2017.01754. PubMed
  83. Luan HH et al. 2019. Cell. 178(5):1231-1244 . PubMed
  84. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  85. Wu X, et al. 2021. Elife. 10:. PubMed
  86. Opzoomer JW, et al. 2021. Sci Adv. 7:eabg9518. PubMed
  87. Ratitong B, et al. 2021. Cell Reports. 35(7):109139. PubMed
  88. Na YR, et al. 2020. Cell Rep. 107643:31. PubMed
  89. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  90. Jacome-Galarza C, et al. 2011. J Bone Miner Res. 26:1207. PubMed
  91. Kotfis K, et al. 2020. British Journal of Pharmacology. 49(1):66-72. PubMed
  92. Jin RM, et al. 2017. J Immunol. 198:352. PubMed
  93. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  94. Lagares D, et al. 2017. Sci Transl Med. 9:eaal3765. PubMed
  95. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  96. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
  97. Korangath P, et al. 2020. Bio Protoc. 10:e3822. PubMed
  98. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  99. Minogue A, et al. 2014. Neurobiol Aging. 35:1442. PubMed
  100. Huixin Xu et al. 2018. EMBO molecular medicine. 10(9) pii: e8931. PubMed
  101. Synn CB, et al. 2022. Clin Transl Immunology. 11:e1364. PubMed
  102. Morales-Mantilla DE, et al. 2022. Elife. 11:. PubMed
  103. Chen M, et al. 2021. Oncol Lett. 21:435. PubMed
  104. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  105. Zheng J, et al. 2020. bioRxiv. . PubMed
  106. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  107. Geng S, et al. 2021. JCI Insight. 6:. PubMed
  108. Gousopoulos E, et al. 2016. Am J Pathol. 186:2193-2203. PubMed
  109. Radjabova V, et al. 2015. J Immunol. 195: 3149 - 3159. PubMed
  110. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  111. Patel S, et al. 2019. Viruses. 0.877083333. PubMed
  112. Mishra BB, et al. 2017. Nat Microbiol. 2:17072. PubMed
  113. Roy K, et al. 2019. Immunity. 50:616. PubMed
  114. Bradley KC, et al. 2019. Cell Rep. 28:245. PubMed
  115. Christ A, et al. 2018. Cell. 172:162. PubMed
  116. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  117. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  118. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  119. Wu M, et al. 2013. Proc Natl Acad Sci U S A. 110:9439. PubMed
  120. Weinheimer-Haus E, et al. 2014. PLoS One. 9:91355. PubMed
  121. Ericson J, et al. 2014. PLoS One. 9:108553. PubMed
  122. Shih Y, et al. 2015. JPEN J Parenter Enteral Nutr. . PubMed
  123. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  124. Li Z, et al. 2018. Front Immunol. 9:347. PubMed
  125. He J, et al. 2019. J Clin Invest. 130. PubMed
  126. Yu L, et al. 2019. Elife. 8:e46677. PubMed
  127. Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
  128. Flögel U, et al. 2021. Nat Commun. 12:5847. PubMed
  129. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  130. Kim P, et al. 2015. Infect Immun . 83: 2992 - 3002. PubMed
  131. Fischer KJ, et al. 2019. J Immunol. 202:2027. PubMed
  132. Challa TD, et al. 2020. Cell Reports. 30(10):3424-3433. PubMed
  133. Liu C et al. 2019. Immunity. 51(2):381-397 . PubMed
  134. Uderhardt S, et al. 2019. Cell. 177:541. PubMed
  135. Hermetet F, et al. 2019. Nat Commun. 10:523. PubMed
  136. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  137. Shevchenko MA, et al. 2018. J Immunol Res. 8:53. PubMed
  138. Covarrubias AJ, et al. 2020. Nat Metab. 1265:2. PubMed
  139. Zheng J, et al. 2020. Nature. . PubMed
  140. Simpson K, et al. 2012. J Immunol. 189:5533. PubMed
  141. Robinett RA et al. 2018. Cell systems. 7(1):41-48 . PubMed
  142. Rebecca S Dickinson et al. 2017. Wellcome open research. 0.155555556 . PubMed
  143. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  144. Nuro-Gyina PK, et al. 2021. J Immunol. 207:868. PubMed
  145. Giampazolias E, et al. 2021. Cell. . PubMed
  146. Prizant H, et al. 2021. Cell Reports. 36:109523. PubMed
  147. Xu P, et al. 2020. Cancer Immunol Res. 8:1193. PubMed
  148. Winchell CG, et al. 2020. Front Immunol. 1.077083333. PubMed
  149. Li YT, et al. 2019. Elife. 8:e47642. PubMed
  150. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  151. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  152. Takaku S, et al. 2022. Evid Based Complement Alternat Med. 2022:6122955. PubMed
  153. Qin W, et al. 2022. Bio Protoc. 12:e4287. PubMed
  154. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  155. Shibuya M, et al. 2021. iScience. 24:103131. PubMed
  156. Taya M, et al. 2020. Endocr Relat Cancer. 27:261. PubMed
  157. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  158. Xu G, et al. 2020. Cell Rep. 32:108170. PubMed
  159. Gorina R, et al. 2014. J Immunol. 192:324. PubMed
  160. Nacer A, et al. 2014. PLoS Pathog. 10:1004528. PubMed
  161. Gamradt P, et al. 2016. PLoS Pathog. 12:e1006032. PubMed
  162. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  163. Thomas DG et al. 2018. Cell reports. 25(13):3774-3785 . PubMed
  164. Lai SM et al. 2018. Cell reports. 25(11):3099-3109 . PubMed
  165. Chen ST et al. 2019. Cell host & microbe. 25(4):602-616 . PubMed
  166. Njock MS, et al. 2022. J Extracell Vesicles. 11:e12228. PubMed
  167. Makino A, et al. 2021. iScience. 24:103201. PubMed
  168. Gao Z, et al. 2022. J Inflamm Res. 15:3337. PubMed
  169. Varikuti S, et al. 2020. Br J Cancer. 122:1005. PubMed
  170. Cartwright ANR, et al. 2021. Cancer Immunol Res. 9:470. PubMed
  171. LeBlond ND, et al. 2020. J Lipid Res. 61:1697. PubMed
  172. Zhu YP et al. 2018. Cell reports. 24(9):2329-2341 . PubMed
  173. van Geffen C, et al. 2021. Front Immunol. 12:695933. PubMed
  174. Gu H, et al. 2021. Elife. 10:. PubMed
  175. Issah Y, et al. 2021. Elife. 10:. PubMed
  176. Wei Y, et al. 2021. Endocrinology. 162(8):. PubMed
  177. Asadi Shahmirzadi A, et al. 2020. Cell Metabolism. 32(3):447-456.e6. PubMed
  178. Xu C, et al. 2020. Immunity. 53(2):417-428.e4. PubMed
  179. Sparber F, et al. 2019. Cell Host Microbe. 25:389. PubMed
  180. Gong P, et al. 2022. Cell Death Discov. 8:466. PubMed
  181. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  182. Danzer H, et al. 2020. Elife. 9:00. PubMed
  183. Chen J, et al. 2014. Cell Res. 24:1050. PubMed
  184. Xu Y, et al. 2014. Proc Natl Acad Sci U S A. 111:6371. PubMed
  185. Willemze RA, et al. 2019. Mol Med. 25:01:00. PubMed
  186. Jain A, et al. 2020. Nat Immunol. 0.920138889. PubMed
  187. Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed
  188. Smith LK, et al. 2021. Elife. 10:. PubMed
  189. Schmit T, et al. 2022. Cell Rep. 38:110456. PubMed
  190. Lee GR, et al. 2021. JCI Insight. 6:. PubMed
  191. Stadtmann A, et al. 2015. J Immunol. 195: 1152-1161. PubMed
  192. Jia H, et al. 2016. J Immunol. 197: 859 - 871. PubMed
  193. Li Z et al. 2018. Immunity. 49(4):640-653 . PubMed
  194. Lee EKS, et al. 2018. Cell Host Microbe. 23:121. PubMed
  195. Dyer DP et al. 2019. Immunity. 50(2):378-389 . PubMed
  196. Orr MT, et al. 2019. NPJ Vaccines. 4:1. PubMed
  197. Geng S, et al. 2019. Sci Adv. 5:eaav2309. PubMed
  198. Rappe JCF, et al. 2021. J Exp Med. 218:. PubMed
  199. Rivera CA, et al. 2022. Immunity. 55:129. PubMed
  200. Awida Z, et al. 2021. Int J Mol Sci. 23:. PubMed
  201. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
  202. Zhang H, et al. 2022. Commun Biol. 5:916. PubMed
  203. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  204. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  205. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  206. Singh N, et al. 2016. Dis Model Mech. 9: 885 - 897. PubMed
  207. Cojohari O, Peppenelli M, Chan G 2016. Blood. 128: 529 - 541. PubMed
  208. Buschor S, et al. 2017. PLoS Pathogens. 13(6):e1006476. PubMed
  209. Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed
  210. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
  211. Chuang LT, et al. 2021. Molecules. 26:. PubMed
RRID
AB_1236488 (BioLegend Cat. No. 127605)
AB_1236494 (BioLegend Cat. No. 127606)

Antigen Details

Structure
A 21-35 kD GPI-anchorded membrane protein
Distribution

Expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes. The monoclonal antibody RB6-8C5 recognizes both Ly-6G and Ly-6C.

Cell Type
Granulocytes, Macrophages, Monocytes
Biology Area
Immunology, Innate Immunity
Antigen References

Fleming TJ, et al. 1993. J. Immunol. 151:2399.

Gene ID
546644 View all products for this Gene ID
UniProt
View information about Ly-6G on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All Ly-6G Reagents Request Custom Conjugation
Description Clone Applications
Purified anti-mouse Ly-6G (Maxpar® Ready) 1A8 FC,CyTOF®,WB
Brilliant Violet 650™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 711™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 605™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 785™ anti-mouse Ly-6G 1A8 FC
PE/Dazzle™ 594 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 750 anti-mouse Ly-6G 1A8 FC
PerCP anti-mouse Ly-6G 1A8 FC
TotalSeq™-A0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-C0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-B0015 anti-mouse Ly-6G 1A8 PG
Spark Blue™ 550 anti-mouse Ly-6G 1A8 FC
Spark NIR™ 685 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 594 anti-mouse Ly-6G 1A8 IHC-F,SB
Purified anti-mouse Ly-6G 1A8 FC,IHC-F,IHC-P,SB
Biotin anti-mouse Ly-6G 1A8 FC,IHC
FITC anti-mouse Ly-6G 1A8 FC
PE anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 647 anti-mouse Ly-6G 1A8 FC,IHC-F,SB
Pacific Blue™ anti-mouse Ly-6G 1A8 FC
APC anti-mouse Ly-6G 1A8 FC
PerCP/Cyanine5.5 anti-mouse Ly-6G 1A8 FC
PE/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 700 anti-mouse Ly-6G 1A8 FC,IHC
APC/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 488 anti-mouse Ly-6G 1A8 FC,IHC-F,SB
Brilliant Violet 421™ anti-mouse Ly-6G 1A8 FC,IHC-F
Brilliant Violet 570™ anti-mouse Ly-6G 1A8 FC
Ultra-LEAF™ Purified anti-mouse Ly-6G 1A8 FC,Depletion,IHC
Brilliant Violet 510™ anti-mouse Ly-6G 1A8 FC
Spark YG™ 593 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
PE/Cyanine5 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
Spark UV™ 387 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 640 anti-mouse Ly-6G 1A8 FC
Spark YG™ 570 anti-mouse Ly-6G 1A8 IHC-F,FC
Spark Red™ 718 anti-mouse Ly-6G (Flexi-Fluor™) 1A8 FC
Spark Blue™ 574 anti-mouse Ly-6G (Flexi-Fluor™) 1A8 FC
PerCP/Fire™ 806 anti-mouse Ly-6G 1A8 FC
StarBright UltraViolet 575 anti-mouse Ly-6G 1A8 FC
Spark PLUS YG581™ anti-mouse Ly-6G 1A8 FC
Go To Top Version: 3    Revision Date: 01/06/2017

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account